MW 4195.87 g/mol. Endogenous apelin receptor (APJ) agonist (EC50 = 20 nM). Exhibits cardioprotective effect and inhibits entry of HIV-1 and HIV-2 into NP-2/CD4 cells. Active in vivo.
MW 4195.87 g/mol. Endogenous apelin receptor (APJ) agonist (EC50 = 20 nM). Exhibits cardioprotective effect and inhibits entry of HIV-1 and HIV-2 into NP-2/CD4 cells. Active in vivo.
Soluble in water to 10 mg/ml.
Endogenous apelin receptor (APJ) agonist (EC50 = 20 nM). Exhibits cardioprotective effect and inhibits entry of HIV-1 and HIV-2 into NP-2/CD4 cells. Active in vivo.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab141009, Apelin 36 (human), Endogenous apelin receptor (APJ) agonist
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com